Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
AI Financial CorpAI Financial Corporation Reports $271.5 Million Net Loss in Q1 Fiscal 2026
LVPAI GROUP LtdLVPAI Group Limited Reports No Revenue and $30,385 Net Loss for Fiscal Year Ending January 31, 2026
BT Brands, Inc.BT Brands Reports Increased Net Loss and Decreased Revenue for 13-Week Period Ending March 29, 2026
Crown PropTech AcquisitionsCrown PropTech Acquisitions Reports Increased Net Loss and Extends Business Combination Deadline
NewHold Investment Corp. IIINewHold Investment Corp. III Reports Q1 2026 Financial Results with Increased Net Income
Catheter Precision, Inc.Catheter Precision Reports 202% Revenue Growth to $432,000 in Latest Quarter
ABVC BIOPHARMA, INC.ABVC BioPharma Reports $1.69 Million Net Loss in Q1 2026, No Revenue Generated
BRADY CORPBrady Corporation Reports 13.8% Increase in Net Sales for Three Months Ended April 30, 2026
OS Therapies IncOS Therapies Reports $10.4 Million Net Loss and Increased R&D Spending in Latest 10-Q Filing
OLB GROUP, INC.OLB Group Reports 28.7% Revenue Decline to $1.66 Million in Q1 2026
VPR Brands, LP.VPR Brands Reports Q1 2026 Financial Results with Significant Profit Turnaround
iSpecimen Inc.iSpecimen Inc. Reports 85% Revenue Decline and Increased Net Loss in Latest 10-Q Filing
Estrella Immunopharma, Inc.Estrella Immunopharma Reports $2.3 Million Net Loss and Increased Operating Expenses for Q1 2026
Versus Systems Inc.Versus Systems Reports 91% Revenue Decline in Q1 2026, Faces Financial Challenges
GENERATION INCOME PROPERTIES, INC.Generation Income Properties Reports Q1 2026 Revenue Decline and Increased Net Loss
DATA I/O CORPData I/O Corporation Reports 47.4% Decline in Q1 2026 Net Sales
Alaunos Therapeutics, Inc.Alaunos Therapeutics Reports Q1 2026 Financial Results with $1.0 Million Net Loss
Silexion Therapeutics CorpSilexion Therapeutics Reports $2.7 Million Net Loss in Q1 2026
TuHURA Biosciences, Inc./NVTuHURA Biosciences Reports $7.5 Million Net Loss in Q1 2026, Increases R&D Spending
Aterian, Inc.Aterian, Inc. Reports 72% Revenue Decline and $6.1 Million Net Loss in Q1 2026
AMAZE HOLDINGS, INC.Amaze Holdings Reports 679% Revenue Growth but Faces Increased Net Loss in Latest Quarter
BioNexus Gene Lab CorpBioNexus Gene Lab Corp. Reports 99% Revenue Decline in Q1 2026
PIONEER POWER SOLUTIONS, INC.Pioneer Power Solutions Reports 36.7% Revenue Decline and $2.5 Million Net Loss in Q1 2026
byNordic Acquisition CorpbyNordic Acquisition Corporation Reports Q1 2026 Financial Results with Increased Net Loss
Churchill Capital Corp X/CaymanInfleqtion Reports $9.5 Million Revenue with 14% Growth and $30.3 Million Net Loss for Q1 2026